Ethics statement The studies involving humans were approved by EudraCT No: 2015-001628-45
Seven (9.3%) were obese and changed category to overweight, and 2 (2.7%) were overweight and changed category to normal BMI
The M6 study (Macrovascular and Microvascular Morbidity and Mortality after Metabolic Surgery versus Medicines) tracked 3,932 adults with obesity and diabetes who received care at Cleveland Clinic for up to a decade
De ce fait galement, les risques d'apparition d'effets indsirables du produit par voie orale (pisodes diarrhiques) sont diminus
Whether youre comparing Wegovy to comprehensive programs or evaluating different medical weight loss options, focus on programs that offer: Proven results with realistic timelines based on clinical data Medical supervision to optimize your treatment and manage any challenges Comprehensive support beyond just medication Transparent pricing without hidden costs or insurance complications Why The Data Matters The difference between 6% and 13% weight loss in your first 12 weeks isnt just about numbersits about momentum, confidence, and reaching your goals in a timeframe that keeps you motivated throughout your journey
Low blood sugar (hypoglycemia) is also a common side effect when used in people taking certain other diabetes treatments (like sulfonylureas or insulin) and can be serious